U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 06:52:03 GMT 2023
Edited
by admin
on Sat Dec 16 06:52:03 GMT 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type
Sequence Type COMPLETE
Record UNII
6KA1906BLC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PINATUZUMAB VEDOTIN
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
ACD22-VCMMAE
Code English
DCDT2980S
Code English
FCU2703
Code English
RO-5541072-000
Code English
ACD-22VCMMAE
Code English
pinatuzumab vedotin [INN]
Common Name English
ANTI-CD22-MONOMETHYL AURISTATIN E ANTIBODY-DRUG CONJUGATE
Common Name English
ACD-22-VCMMAE
Code English
PINATUZUMAB VEDOTIN [USAN]
Common Name English
FCU-2703
Code English
RG-7593
Code English
IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS CD22 (SIALIC ACID BINDING IG-LIKE LECTIN 2, SIGLEC2, SIGLEC-2, BLYMPHOCYTE CELL ADHESION MOLECULE, BL-CAM, LEU-14)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDING IMMUNOGLOBULIN-LIKE LECTIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MCDT2219A .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-
Systematic Name English
RO-5541072000
Code English
RO5541072-000
Code English
Pinatuzumab vedotin [WHO-DD]
Common Name English
DCDT-2980S
Code English
Code System Code Type Description
USAN
AB-128
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
ChEMBL
CHEMBL2109272
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
NCI_THESAURUS
C104167
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
CAS
1313706-14-7
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
FDA UNII
6KA1906BLC
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
ChEMBL
CHEMBL3301585
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
INN
9713
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
WIKIPEDIA
Pinatuzumab vedotin
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
DRUG BANK
DB15432
Created by admin on Sat Dec 16 06:52:03 GMT 2023 , Edited by admin on Sat Dec 16 06:52:03 GMT 2023
PRIMARY
From To
1_22 1_96
1_147 1_203
1_223 3_219
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
2_22 2_96
2_147 2_203
2_264 2_324
2_370 2_428
2_223 4_219
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:CALCULATED CHEMICAL